PR PRAR ARAM AM 9 9 HO HOSP SPITAL ITAL Analyst lyst Me - PowerPoint PPT Presentation

PR PRAR ARAM AM 9 9 HO HOSP SPITAL ITAL Analyst lyst Me Meeti ting ng : 1Q20 0 Resu sult lts 25 25 Ma May y 2020 2020

Pro rofessio fessional nal Heal althcare thcare Commu mmunit nity ใส่ใจสุขภาพ ดูแลด้วยมืออาชีพ VI VISION SION & MILE MI LESTO STONE NES P. P.2

Agenda 1 Overview rview & PR9 ’ s s Strength engths 2 Ope perat rational ional Statisti atistics cs & Fin inancial ancial Performance formance 3 PR PR9 9 Strategies ategies 4 Busine Bu siness ss Upd pdate ate & Proje oject ct Updat pdate P. P.3

Agenda 1 Overview rview & PR9 ’ s s Strength engths 2 Ope perat rational ional Statisti atistics cs & Fin inancial ancial Performance formance 3 PR PR9 9 Strategies ategies 4 Busine Bu siness ss Upd pdate ate & Proje oject ct Updat pdate P. P.4

Company Milestones Kidney Transplant Joint Commission 4D Ultrasound International Listed ed in the Stock ck Exchange ange Excellen llence ce Telemedicine emedicine Started rted hospita ital opera ratio tion, n, with h Started rted using Accred redit it Effectiv ctive e 500 Kidney 500 ey Started rted new buildi ding g of Thailand land, , with h THB 800 800 CG Scoring ring Platfo form rm THB 400 400 mm regi gister ered ed capita ital 4D U Ultra rasou ound nd Status by JCI Transp nsplant lant Cases es constructio truction mm regis istered tered capit ital al 2019 2019 1992 1992 2001 2001 2004 2004 2005 2005 2010 2010 2013 2013 2016 2016 2017 2017 2020 2020 2018 2018 st privat st privat Increas reased ed regis istered tered 1 st ate e hospita tal l Accred redited ited CCPC PC for 1 st 900 900 Kidney ey Implementati lementation on of ate e hospita tal l Signed ed Kidney ey capit ital al to THB 600 600 mm mm with 64 64 Slice ce CT Scan Kidney ey Transp nsplant lant Transp nsplant lant Cases es Pharm rmacy acy Robot with 640 640 Slice ce CT Scan refer erral ral MOUs MOU – Kidney Referral 64 Slice CT Scan Pharmacy Robot 640 Slice CT Scan P. P.5

Company Overview - Started hospital operation in 1992 (registered capital of THB 400 mm) by the group of excellence doctors who had the passion to build a high quality of hospital (Tertiary Care) with the reasonable price - Current capacity : 166 IPD beds and 114 OPD Exam rooms - JCI Accreditation : with 2 Medical Institutes and 22 Medical Centers ➢ Kidney Disease & Transplant Institutes (JCI CCPC, Clinical Care Program Certification) ➢ Cardiovascular Institutes - 4 Core Competency : Kidney / Diabetes / Cardio / Minimal Invasive Surgery - Highest number of Kidney Transplant cases among the private hospital in Thailand ( >900 cases) - No. of Doctor and Medical Staff : Dec 2019 More than 500 specialist doctors Full l Time e Docto tor 113 113 Part t Time e Doctor or 456 456 Consu sult ltant ant 176 176 351 351 Nurs rse Other er Medical cal Staff ff 493 493 Other er Depar artm tment ent 486 486 Total al 2,07 075 P. P.6

PR9 Overview Snapshot ✓ 2010 / 2013 / 2 2016 / 2019 – JCI (4th accredited) 2 Medical Institutes plus 22 Medical Centers Accreditation ✓ 2016 / 2019 - CCPC: Kidney Medical ✓ 2004 / / 2007 2007 - HA Level 3 Cardiovascular Kidney Disease & Institute Transplant Institute ✓ 2000 - ISO 9001:1994 ✓ 2003 - ISO 9001:2000 Diabetes & Metabolic Breast Clinic Hair Center Center − 2017 17 : 640 40-sli lice e CT Scan Technology − 2016 16 : Pharmac macy Robo bot t Obstetric Orthopedic Mind Center − 2005 05 : 64-sli lice ce CT Scan Center Gynecology Center − 2004 04 : 4D Ultra trasound und Pediatrics Eye Center Surgery Center 2019 : Excellent CG Scoring Center The Stock Exchange of Thailand & Thai Institute of Directors Check-Up 2019 : Good Governance Hospital Certificate Medicine Center Dental Center Other Key Achievements Center Department of Internal Trade, Ministry of Commerce 2019 : Thailand ’ s Most Admired Company: No.4 in Private Hospital Sector Imaging Center Physical Therapy & Ear Nose and (X-Ray) BrandAge magazine Throat Center Rehabilitation Center 2019 : Thailand Top Company Awards 2019: Healthcare Sector (2 nd year) Gastroenterology (GI) Neurology Skin and Cosmetic Business+ magazine & University of the Thai Chamber of Commerce and Hepatobiliary Center Laser Surgery Center (Liver) Center 2019 : Muang Thai Life Assurance Hospital Awards 1St Runner Up : Innovations Hospital Awards Joint Care Emergency Center Thyroid Center Center 2017 : Best Utilization Award AXA Provider Award 2017 : Fertility Service Provider of the Year W9 Wellness Center Global Health and Travel Awards 2017 P. P.7

PR9 ’ s Strengths ➢ Comp mplex lex Med edical cal Tr Trea eatments tments Tertiary-care hospital with world class medical quality & Excellence Doctors • JCI Accreditation plus specialty accreditation (Kidney Disease and Transplant Institute) ➢ Value ue fo for Money ey Ser ervice vices s PR9 ’ s Pricing policy with International Standard of tertiary care and high class service quality • => Good Governance Hospital Certificate: Department of Internal Trade, Ministry of Commerce ➢ Strate rategic gic Lo Locat ation ion in New New CB CBD Prime location with strong healthcare demand and promising growth opportunities • => High density populated area (office building / residential commute / embassy / life-style center etc.), including the new Chinese expat community P. P.8

Complex Medical Treatments & Excellence Doctors “ โรคซับซ้อน โรคเรื้อรัง เราเชี่ยวชาญ ” ด้วยทีมแพทย์เฉพาะทาง มากกว่า 500 ท่าน P. P.9

Value for Money Services One of our ur philosophy losophy : W : We ai aim m to deli liver ver excell ellence ence medica ical l car are e in consideration of “Value for Money” for our patients e “ Gr Green een-Rate Rated ” Ho Rec ecei eived ved the Hospital al From om Dep epartment artment of of Int ntern ernal al Trade ade, , Ministr nistry of of Com omme merc rce : Offer er Frien endly dly Medic edicine ine Pricing cing for the e Patients ents https: s://hospi hospita tals. ls.di dit. t.go go.t .th/a h/app pp/dr drug_ g_pr price_sea ice_search ch.p .php hp P.10 P. 10

Strategic Location in New CBD ew CBD area Locat Lo ated ed in New ea & ew China-Tow Town n (Hua New uai Khwang ng-Ra Ratcha chada da) Note (1): Include Huaykwang, Makkasan, Klong Teoy Nuea, Klong Tun Nuea, Bangkapi, Dindang area P. P.11 11

Agenda 1 Overview rview & PR9 ’ s s Strength engths 2 Ope perat rational ional Statisti atistics cs & Fin inancial ancial Performance formance 3 PR PR9 9 Strategies ategies 4 Bu Busine siness ss Upd pdate ate & Proje oject ct Updat pdate P. P.12 12

Financial Summary Due to the Coron ronav avir irus diseas ase e 2019 2019 situatio tion, , PR9 9 repo ported rted total al medi dical cal revenue enue in 1Q20 20 of Baht ▪ 658.9 millio lion, n, a decre creas ase e of 5.2% from om 1Q19 19. As a r result lts of a slightly tly decreas rease e of OPD revenu nue, e, while le venue nue IPD revenu nue e in decreas reased ed at 10.7% % yoy. 695.2 658.9 cal Reve Medica ical l reven enue e from om Thai patien ent t dropp pped ed 5.9% % yoy, while le intern ernat atio ional nal patien ients ts slight htly ly dropp pped ed ▪ 500.0 .0 1.6% % yoy. Thank nks to the growth wth from m Chine nese e patien ent t group p that t help the internatio ernational nal patien ent t segmen ent dica rece ceiv ived ed less impact act. Medi 0.0 While e insura rance nce and corp rpor orat ate contra tract ct paymen ent t meth thod ods dropp pped ed from om the diseas ase e contro trol l meas asures res, , ▪ 1Q20 Q2019 1Q20 Q2020 while le the insura rance nce custom omer ers grew w up from om the tenden ency cy of more re healt lth h insura rance nce usage. 400.0 .0 20.4% 300.0 .0 12.6% EBITDA DA ▪ PR PR9 9 repor orted ed EBITDA A in 1Q20 20 of Baht 84.0 millio lion, n, a d decrea crease e of 41.4% from om Baht 143.4 millio lion in 1Q19 19, , 200.0 200. 143.4 .4 while le the EBITDA A margi gin n were e 12.6% in 1Q20 20 and 20.4% in 1Q19 19. . 84.0 .0 100.0 .0 0.0 1Q20 Q2019 1Q20 Q2020 400. 400.0 300. 300.0 fit 12.2% ▪ In 1Q20 20, PR9 9 repor orted ed profi fits ts for r the perio iod d Baht 37.3 mill llio ion, n, a decreas rease e of 56.6% from m Baht 86.1 t Profi 200.0 .0 5.6% millio lion n in 1Q19 19, repr presenting nting the net profi fit t marg rgin in for the peri riod od of 12.2% and 5.6% respect pectiv ively ely. 86.1 .1 Net 100.0 .0 37.3 .3 0.0 1Q20 Q2019 1Q20 Q2020 P. P.13 13